2020 journal article
Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers
JOURNAL OF VETERINARY CARDIOLOGY, 30, 77–91.